Emergent BioSolutions to begin ‘improvements’ at Baltimore facility as J&J evaluates Covid vaccine demand
February 28, 2022 5:05 am Comments Off on Emergent BioSolutions to begin ‘improvements’ at Baltimore facility as J&J evaluates Covid vaccine demandGaithersburg’s Emergent BioSolutions Inc. (NYSE: EBS) plans to begin “facility improvements” at its Baltimore manufacturing plant as Johnson & Johnson Read More